Study Overview: This study is testing a new treatment called **Viaskin® Peanut Patch** for very young children (1-3 years old) with peanut allergies. We want to see if it's safe to use for 6 months. The patch gives a tiny amount of peanut protein through the skin to help the body get used to peanuts.
Study Details: The study lasts for about 112 weeks in total. It starts with a **6-week screening** to check if your child is a good match. Then, there are three parts: a **26-week treatment** period with either the real patch or a placebo (a patch with no active ingredient), a **78-week open-label extension** where all participants receive the real patch, and a **2-week follow-up**.
Key Points:
- The study involves regular visits to the clinic for monitoring your child's safety and health.
- Participants will be randomly assigned to receive either the real treatment or placebo first, but everyone has the chance to try the real patch later.
- It's important that your child continues to follow a peanut-free diet during the study.
How understandable was the trial content above?
Hard to understand
Easy to understand